Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders
-
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
-
Allegro MicroSystems to Announce Third Quarter Fiscal Year 2026 Financial Results
-
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
-
SKYX Announces Collaboration with NVIDIA on its Connect Program, Cloud, and AI Ecosystem for its Patented Ceiling All-In-One Smart Home Platform and Hub
-
EU9 Strengthens Mobile Accessibility Across Its Digital Platform
-
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy
-
Midland, in Partnership with Rio Tinto Exploration Canada, Intersects New Lithium and Cesium Bearing Pegmatites During the 2025 Drilling Program on the Galinée Project
-
GURU Organic Energy to Report Fourth Quarter and Fiscal Year 2025 Results
-
Electra Provides Update on Refinery Project Progress
-
AGF Investments Launches ETF Series for Legacy Funds: AGF American Growth Fund and AGF Global Select Fund
-
Beneficient Enters into $3 Million GP Primary Capital Transaction
-
North American Niobium and Critical Minerals Corp. Reports Positive Preliminary Soil-Gas Radon Survey Results at Blanchette and Bardy; Phase 2 Planned with Rapid Follow-Up Portable Bedrock Drilling Pr
-
Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases
-
ElevateBio Achieves Sixth Consecutive Year of Revenue Growth Driven by Expansion of its Genetic Medicine Technology and Manufacturing Business
-
AGM Group Announces Strategic Memorandum of Understanding with Amber Premium in Building RWA Tokenization Initiatives
-
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled
-
Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
-
ZenaTech Completes 20th Acquisition in Year One of Drone as a Service, Strengthening California Wildfire Management and Public Works Opportunities
-
Dragonfly Energy Issues Year-End CEO Letter to Shareholders
-
Atsena Completes Dosing in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis and Announces Plans for Initiation of Pivotal Part C Cohort
-
Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology
-
Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
-
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
-
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Public Affairs, Reputation and Issues Management Expert Joshua Baca Joins FTI Consulting
-
Form 8.3 - [IDOX PLC - 07 01 2026] - (CGWL)
-
Form 8.3 - Idox Plc
-
Form 8.3 - Empiric Student Property Plc
-
Form 8.3 - [IDOX PLC - 07 01 2026] - (CGAML)
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Exodus Movement, Inc. December 2025 Treasury Update and Monthly Metrics
-
Withdrawal of Letter of Intent - IDOX plc - 08 01 2026 - (CGAML)
-
Gilat to Participate in the 28th Annual Needham Growth Stock Conference on Tuesday, January 13
-
Aurora Spine Announces Issuance of Two U.S. Patents
-
Aurora Spine Announces Issuance of Two U.S. Patents
-
SRx Health Solutions Regains Compliance with NYSE
-
Howard Hughes Holdings Inc. Announces Dates and Times for 2025 Fourth Quarter Earnings Release and Conference Call
-
SchoolAI Research Challenges Fears About AI in the Classroom with Evidence From 23,000 Teacher-Created Lessons
-
Microchip Releases Custom Firmware For NVIDIA DGX Spark For Its MEC1723 Embedded Controllers
-
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
-
Beacon Therapeutics Announces Closing of Oversubscribed Series C Financing for Over $75 Million
-
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
-
Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy
-
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
-
Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
-
The Simply Good Foods Company Reports Fiscal First Quarter 2026 Financial Results and Reaffirms Fiscal Year 2026 Outlook
-
Xali Gold Commences Work on Pico Machay Gold Project in Peru
-
Aronora Appoints Industry Leaders to Drive Next Phase of Growth
